greeksoup/ stock research

Intuitive Surgical (ISRG) Q2 FY2026 earnings: revenue $2.9 billion, up 18.5% on the year

Intuitive Surgical Inc. (ISRG) reported revenue of $2.9 billion for Q2 FY2026, the quarter ended 30 June 2026, up 18.5% on the same quarter a year earlier. Net income was $818 million, up 24.3% on the year, and diluted earnings per share $2.29. The figures are the company's own, from the 10-Q it filed with the SEC on 21 July 2026.

Revenue
$2.9 billion
+18.5% on the year · +4.4% on the quarter
Q3 FY2024Q2 FY2026
Operating margin
33.6%
30.5% a year earlier
Q3 FY2024Q2 FY2026
Net income
$818 million
+24.3% on the year · -0.4% on the quarter
Q3 FY2024Q2 FY2026
Diluted EPS
$2.29
+26.5% on the year · +0.4% on the quarter
Q3 FY2024Q2 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

What management said

Guidance figures: 1 raised, 1 narrowed, 2 kept.

  • Revenue rose 19% to $2.89 billion: Revenue was $2.89 billion, up from $2.44 billion a year earlier. Management attributed the increase to procedure volume growth, higher da Vinci system leasing revenue, and a larger installed base.
  • Worldwide procedures grew about 16%: Da Vinci and Ion procedures combined rose about 16% against the prior-year quarter. Ion procedures grew faster than da Vinci procedures in the period.
  • Non-GAAP EPS rose to $2.80: Non-GAAP net income was $1.00 billion, or $2.80 per diluted share, versus $2.19 a year earlier. GAAP diluted EPS was $2.29, against $1.81 a year earlier.
Read the earnings call summary

Income statement (profit and loss)

$ millionQ2 FY2026Q1 FY2026Q2 FY2025On the quarterOn the yearLast 8 quarters
Revenue2,8922,7712,440+4.4%+18.5%
Cost of revenue932940822-0.9%+13.4%
Gross profit1,9601,8301,618+7.1%+21.2%
Gross margin67.8%66.1%66.3%
Research and development371362313+2.4%+18.3%
Selling, general and administrative618613561+0.8%+10.1%
Operating income972855743+13.6%+30.7%
Operating margin33.6%30.9%30.5%
Pre-tax income1,055940832+12.1%+26.7%
Income tax231114168+102.3%+37.8%
Effective tax rate21.9%12.2%20.2%
Net income818822658-0.4%+24.3%
Net margin28.3%29.6%27.0%
Diluted EPS$2.29$2.28$1.81+0.4%+26.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ2 FY2026Q1 FY2026Q2 FY2025On the quarterOn the yearLast 8 quarters
Operating cash flow1,061912715+16.4%+48.3%
Capital expenditure113103155+9.0%-27.5%
Free cash flow948809560+17.3%+69.3%
Free cash flow margin32.8%29.2%23.0%
Cash from investing-26.6-914261
Cash from financing-288-1,354-148
Share-based compensation213210200+1.6%+6.5%
Buybacks3201,123181-71.5%+77.0%
Diluted shares, weighted357m360m364m-0.7%-1.9%
Shares outstanding at period end354m354m358m-0.1%-1.3%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ2 FY2026Q1 FY2026Q2 FY2025On the quarterOn the yearLast 8 quarters
Shareholders' equity18,16817,47417,846+4.0%+1.8%
Non-controlling interest129123107+5.4%+20.4%
Debt0.00.00.0
Other liabilities2,5792,5142,210+2.6%+16.7%
Total liabilities and equity20,87720,11120,163+3.8%+3.5%
Fixed assets5,5525,4484,985+1.9%+11.4%
Goodwill581613349-5.3%+66.5%
Intangible assets19817417.9+14.1%+1,006.1%
Investments5,8655,9736,129-1.8%-4.3%
Cash and equivalents2,7602,0063,403+37.6%-18.9%
Receivables1,6731,5961,269+4.9%+31.8%
Inventory2,0291,9451,667+4.3%+21.7%
Other assets2,2192,3562,343-5.8%-5.3%
Total assets20,87720,11120,163+3.8%+3.5%

Questions

What was Intuitive Surgical's revenue in Q2 FY2026?

Intuitive Surgical (ISRG) reported revenue of $2.9 billion for Q2 FY2026, the quarter ended 30 June 2026, up 18.5% on the same quarter a year earlier.

How much did Intuitive Surgical earn in Q2 FY2026?

Net income for Q2 FY2026 was $818 million, up 24.3% on the year, and diluted earnings per share $2.29.

When did Intuitive Surgical report Q2 FY2026 results?

Intuitive Surgical filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 21 July 2026.

Quarterly results, the last 20 quarters

Q4 FY2021Q1 FY2022 †Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue1,5511,4881,5221,5571,6551,6961,7561,7441,9281,8912,0102,0382,4142,2532,4402,5052,8662,7712,8923,049
Cost of revenue490478499505544583584576651645637664771796822843962940932964
Gross profit1,0611,0101,0231,0521,1111,1131,1721,1671,2771,2451,3731,3741,6421,4581,6181,6621,9041,8301,9602,084
Gross margin68%68%67%68%67%66%67%67%66%66%68%67%68%65%66%66%66%66%68%68%
R&D183210207217244245244249260284280286295316313329353362371408
SG&A427391418436494480464452567492525511613563561573687613618633
Operating income450408398399372388463466450469567577735578743760864855972593
Operating margin29%27%26%26%23%23%26%27%23%25%28%28%30%26%30%30%30%31%34%19%
Pre-tax income4544024074033954224995225165386546718106688328559569401,055668
Tax rate16%8%23%19%15%14%15%20%-18%-2%19%15%15%-5%20%17%16%12%22%22%
Net income381366308324325355421416606545527565686698658704795822818523
Net margin25%25%20%21%20%21%24%24%31%29%26%28%28%31%27%28%28%30%28%17%
Diluted EPS$1.03$1.00$0.85$0.90$0.91$1.00$1.18$1.16$1.69$1.51$1.46$1.56$1.88$1.92$1.81$1.95$2.21$2.28$2.29$1.49
Operating cash flow5682234473834383716665482282656207068235827158418929121,0611,224
Capital expenditure15193.6130169138194178256436242309248312117155105162103113113
Free cash flow417129316214300177487292-20723.53114595114655607367308099481,111
Buybacks0.01065001,0001,0013500.00.066.30.00.00.00.00.01811,9132011,1233202,976
Dividends paidn/an/an/an/an/an/an/a0.0n/an/an/a0.0n/an/an/a0.0n/an/an/an/a
Shares outstanding358m359m357m353m350m350m351m352m352m355m355m356m357m358m358m355m355m354m354m347m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 June 2026, filed 21 July 2026: the filing.